Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial

por Venter, Willem D. F., Majam, Mohammed, Akpomiemie, Godspower, Arulappan, Natasha, Moorhouse, Michelle, Mashabane, Nonkululeko, Chersich, Matthew F.
Publicado 2017

Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy

por Steel, Helen C., Venter, W. D. Francois, Theron, Annette J., Anderson, Ronald, Feldman, Charles, Arulappan, Natasha, Rossouw, Theresa M.
Publicado 2021

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial

por Venter, Willem Daniel Francois, Kambugu, Andrew, Chersich, Matthew F., Becker, Stephen, Hill, Andrew, Arulappan, Natasha, Moorhouse, Michelle, Majam, Mohammed, Akpomiemie, Godspower, Sokhela, Simiso, Poongulali, Selvamuthu, Feldman, Charles, Duncombe, Chris, Ripin, David H. Brown, Vos, Alinda, Kumarasamy, Nagalingeswaran
Publicado 2019

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

por Karim, Quarraisha Abdool, Kharsany, Ayesha BM, Frohlich, Janet A, Baxter, Cheryl, Yende, Nonhlanhla, Mansoor, Leila E, Mlisana, Koleka P, Maarschalk, Silvia, Arulappan, Natasha, Grobler, Anneke, Sibeko, Sengeziwe, Omar, Zaheen, Gengiah, Tanuja N, Mlotshwa, Mukelisiwe, Samsunder, Natasha, Abdool Karim, Salim S
Publicado 2011